NCT00836576View on ClinicalTrials.gov

Benazepril HCl 40 mg Tablets, Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

March 31, 2001

Study Completion Date

March 31, 2001

Conditions
Healthy
Interventions
DRUG

Benazepril HCl 40 mg Tablets

1 x 40 mg, single-dose fasting

DRUG

Lotensin® 40 mg Tablets

1 x 40 mg, single-dose fasting

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00836576 - Benazepril HCl 40 mg Tablets, Fasting | Biotech Hunter | Biotech Hunter